Author:Sciensus
Blogs, Rare diseases
Strategic timing: When should biotech firms consider launching expanded access programs?
News
Sciensus announces chosen charities for next three years
News
Sciensus contributes to new diversity, equity, and inclusion research paper
Blogs
Unlocking business and commercial value with patient-reported data
Blogs
Patient engagement: the golden ticket to drive effective treatments and commercial success
Case Studies, Cancer
Sciensus delivers home-based cancer care to patients in rural areas
Case Studies, Cancer
Interview with Prof. Suneil Jain on prostate cancer treatment
Blogs, Rare diseases
How to set up an EAP without a European presence
News
Sciensus announces two new senior hires as it continues to grow as a leading European life sciences organisation